H1B Salary Data

Home › Employers › AbbVie Inc. › Senior Scientist II

Senior Scientist II at AbbVie Inc.: H-1B salaries

15 labor condition applications for the job title Senior Scientist II at AbbVie Inc.. Median offered base salary $145,000; middle half $137,500–$155,000.

Applications (LCAs)15
Median offered salary$145,000
Middle half of salaries$137,500–$155,000
10th–90th percentile$133,400–$156,071

By fiscal year

Fiscal yearLCAsMedian salary
FY20232$127,500
FY20242$143,500
FY20257$155,000
FY20264$138,562

Applications

Base salaryLocationSubmittedStart dateStatus
$134,000–$154,000
Level IV		North Chicago, ILMay 1, 2026May 11, 2026Certified
$139,124
Level IV		North Chicago, ILApr 1, 2026Oct 1, 2026Certified
$138,000
Level III		North Chicago, ILDec 2, 2025Jan 1, 2026Certified
$155,000
Level IV		North Chicago, ILSep 24, 2025Nov 18, 2025Certified
$155,000
Level IV		North Chicago, ILSep 23, 2025Nov 18, 2025Certified
$138,000–$158,000
Level II		North Chicago, ILSep 4, 2025Sep 15, 2025Certified
$156,785
Level III		Irvine, CAAug 5, 2025Feb 1, 2026Certified
$155,000
Level IV		North Chicago, ILJun 2, 2025Jul 31, 2025Certified
$178,000–$198,000
Level IV		South San Francisco, CAApr 29, 2025Oct 1, 2025Certified
$150,000
Level IV		North Chicago, ILDec 9, 2024Mar 24, 2025Certified
$145,000–$165,000
Level IV		Irvine, CAOct 24, 2024Nov 4, 2024Certified
$137,000–$157,000
Level IV		North Chicago, ILJun 5, 2024Jun 14, 2024Certified
$150,000–$170,000
Level IV		Worcester, MAJun 4, 2024Jun 12, 2024Certified
$133,000–$153,000
Level IV		North Chicago, ILApr 10, 2023Apr 19, 2023Certified
$122,000–$142,000
Level II		North Chicago, ILMar 29, 2023Apr 7, 2023Certified

Senior Scientist II at all employers →

Other jobs at AbbVie Inc.

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).